-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2022 to Q2 2024.
- Dianthus Therapeutics, Inc. /DE/ Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $4.6M, a 623% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $12.1M.
- Dianthus Therapeutics, Inc. /DE/ annual Nonoperating Income (Expense) for 2023 was $4.62M, a 276% increase from 2022.
- Dianthus Therapeutics, Inc. /DE/ annual Nonoperating Income (Expense) for 2022 was $1.23M.
- Dianthus Therapeutics, Inc. /DE/ annual Nonoperating Income (Expense) for 2021 was -$23K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)